Induction of enhanced immunogenic cell death through ultrasound-controlled release of doxorubicin by liposome-microbubble complexes

References

• Galluzzi L, Kepp O, Kroemer G. Enlightening the impact of immunogenic cell death in photodynamic cancer therapy. EMBO J. 2012;31(5):1055–7. doi:10.1038/emboj.2012.2. PMID:22252132.
   PubMed Web of Science ®Google Scholar
• Fahmueller YN, Nagel D, Hoffmann RT, Tatsch K, Jakobs T, Stieber P, Holdenrieder S. Immunogenic cell death biomarkers HMGB1, RAGE, and DNAse indicate response to radioembolization therapy and prognosis in colorectal cancer patients. Int J Cancer. 2013;132(10):2349–58. doi:10.1002/ijc.27894. PMID:23047645.
   PubMed Web of Science ®Google Scholar
• Kroemer G, Galluzzi L, Kepp O, Zitvogel L. Immunogenic cell death in cancer therapy. Annu Rev Immunol. 2013;31:51–72. doi:10.1146/annurev-immunol-032712-100008. PMID:23157435.
   PubMed Web of Science ®Google Scholar
• Krysko DV, Garg AD, Kaczmarek A, Krysko O, Agostinis P, Vandenabeele P. Immunogenic cell death and DAMPs in cancer therapy. Nat Rev Cancer. 2012;12(12):860–75. doi:10.1038/nrc3380. PMID:23151605.
   PubMed Web of Science ®Google Scholar
• Kepp O, Senovilla L, Vitale I, Vacchelli E, Adjemian S, Agostinis P, Apetoh L, Aranda F, Barnaba V, Bloy N, et al. Consensus guidelines for the detection of immunogenic cell death. Oncoimmunology. 2014;3(9):e955691. doi:10.4161/21624011.2014.955691. PMID:25941621.
   PubMed Web of Science ®Google Scholar
• Ladoire S, Enot D, Andre F, Zitvogel L, Kroemer G. Immunogenic cell death-related biomarkers: Impact on the survival of breast cancer patients after adjuvant chemotherapy. Oncoimmunology. 2016;5(2):e1082706. doi:10.1080/2162402X.2015.1082706. PMID:27057465.
   PubMed Web of Science ®Google Scholar
• Obeid M, Tesniere A, Ghiringhelli F, Fimia GM, Apetoh L, Perfettini JL, Castedo M, Mignot G, Panaretakis T, Casares N, et al. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med. 2007;13(1):54–61. doi:10.1038/nm1523. PMID:17187072.
   PubMed Web of Science ®Google Scholar
• Vacchelli E, Ma Y, Baracco EE, Sistigu A, Enot DP, Pietrocola F, Yang H, Adjemian S, Chaba K, Semeraro M, et al. Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1. Science. 2015;350(6263):972–8. doi:10.1126/science.aad0779. PMID:26516201.
   PubMed Web of Science ®Google Scholar
• Tesniere A, Schlemmer F, Boige V, Kepp O, Martins I, Ghiringhelli F, Aymeric L, Michaud M, Apetoh L, Barault L, et al. Immunogenic death of colon cancer cells treated with oxaliplatin. Oncogene. 2010;29(4):482–91. doi:10.1038/onc.2009.356. PMID:19881547.
   PubMed Web of Science ®Google Scholar
• Schiavoni G, Sistigu A, Valentini M, Mattei F, Sestili P, Spadaro F, Sanchez M, Lorenzi S, D'Urso MT, Belardelli F, et al. Cyclophosphamide synergizes with type I interferons through systemic dendritic cell reactivation and induction of immunogenic tumor apoptosis. Cancer Res 2011;71(3):768–78. doi:10.1158/0008-5472.CAN-10-2788. PMID:21156650.
   PubMed Web of Science ®Google Scholar
• Spisek R, Charalambous A, Mazumder A, Vesole DH, Jagannath S, Dhodapkar MV. Bortezomib enhances dendritic cell (DC)-mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implications. Blood. 2007;109(11):4839–45. doi:10.1182/blood-2006-10-054221. PMID:17299090.
   PubMed Web of Science ®Google Scholar
• Zhao X, Yang K, Zhao R, Ji T, Wang X, Yang X, Zhang Y, Cheng K, Liu S, Hao J, et al. Inducing enhanced immunogenic cell death with nanocarrier-based drug delivery systems for pancreatic cancer therapy. Biomaterials. 2016;102:187–97. doi:10.1016/j.biomaterials.2016.06.032. PMID:27343466.
   PubMed Web of Science ®Google Scholar
• Zitvogel L, Kepp O, Senovilla L, Menger L, Chaput N, Kroemer G. Immunogenic tumor cell death for optimal anticancer therapy: the calreticulin exposure pathway. Clin Cancer Res. 2010;16(12):3100–4. doi:10.1158/1078-0432.CCR-09-2891. PMID:20421432.
   PubMed Web of Science ®Google Scholar
• Pozzi C, Cuomo A, Spadoni I, Magni E, Silvola A, Conte A, Sigismund S, Ravenda PS, Bonaldi T, Zampino MG, et al. The EGFR-specific antibody cetuximab combined with chemotherapy triggers immunogenic cell death. Nat Med. 2016;22(6):624–31. doi:10.1038/nm.4078. PMID:27135741.
   PubMed Web of Science ®Google Scholar
• Obeid M. ERP57 membrane translocation dictates the immunogenicity of tumor cell death by controlling the membrane translocation of calreticulin. J Immunol. 2008;181(4):2533–43. doi:10.4049/jimmunol.181.4.2533. PMID:18684944.
   PubMed Web of Science ®Google Scholar
• Luo W, Wen G, Yang L, Tang J, Wang J, Wang J, Zhang S, Zhang L, Ma F, Xiao L, et al. Dual-targeted and pH-sensitive doxorubicin prodrug-microbubble complex with ultrasound for tumor treatment. Theranostics. 2017;7(2):452–65. doi:10.7150/thno.16677. PMID:28255342.
   PubMed Web of Science ®Google Scholar
• Park J, Aryal M, Vykhodtseva N, Zhang YZ, McDannold N. Evaluation of permeability, doxorubicin delivery, and drug retention in a rat brain tumor model after ultrasound-induced blood-tumor barrier disruption. J Control Release. 2017;250:77–85. doi:10.1016/j.jconrel.2016.10.011. PMID:27742444.
   PubMed Web of Science ®Google Scholar
• Zhang K, Xu H, Chen H, Jia X, Zheng S, Cai X, Wang R, Mou J, Zheng Y, Shi J. CO2 bubbling-based ‘Nanobomb’ System for Targetedly Suppressing Panc-1 Pancreatic Tumor via Low Intensity Ultrasound-activated Inertial Cavitation. Theranostics. 2015;5(11):1291–302. doi:10.7150/thno.12691. PMID:26379793.
   PubMed Web of Science ®Google Scholar
• Liu HL, Fan CH, Ting CY, Yeh CK. Combining microbubbles and ultrasound for drug delivery to brain tumors: current progress and overview. Theranostics. 2014;4(4):432–44. doi:10.7150/thno.8074. PMID:24578726.
   PubMed Web of Science ®Google Scholar
• Deng Z, Yan F, Jin Q, Li F, Wu J, Liu X, Zheng H. Reversal of multidrug resistance phenotype in human breast cancer cells using doxorubicin-liposome-microbubble complexes assisted by ultrasound. J Control Release. 2014;174:109–16. doi:10.1016/j.jconrel.2013.11.018. PMID:24287101.
   PubMed Web of Science ®Google Scholar
• Yan F, Li L, Deng Z, Jin Q, Chen J, Yang W, Yeh CK, Wu J, Shandas R, Liu X, et al. Paclitaxel-liposome-microbubble complexes as ultrasound-triggered therapeutic drug delivery carriers. J Control Release. 2013;166(3):246–55. doi:10.1016/j.jconrel.2012.12.025. PMID:23306023.
   PubMed Web of Science ®Google Scholar
• Tartis MS, McCallan J, Lum AF, LaBell R, Stieger SM, Matsunaga TO, Ferrara KW. Therapeutic effects of paclitaxel-containing ultrasound contrast agents. Ultrasound Med Biol. 2006;32(11):1771–80. doi:10.1016/j.ultrasmedbio.2006.03.017. PMID:17112963.
   PubMed Web of Science ®Google Scholar
• Tay LM, Xu C. Coating microbubbles with nanoparticles for medical imaging and drug delivery. Nanomedicine (Lond). 2017;12(2):91–94. doi:10.2217/nnm-2016-0362. PMID:27876447.
   PubMed Web of Science ®Google Scholar
• Snipstad S, Berg S, Morch Y, Bjorkoy A, Sulheim E, Hansen R, Grimstad I, van Wamel A, Maaland AF, Torp SH, et al. Ultrasound improves the delivery and therapeutic effect of nanoparticle-stabilized microbubbles in breast cancer xenografts. Ultrasound Med Biol. 2017;43(11):2651–2669. doi:10.1016/j.ultrasmedbio.2017.06.029. PMID:28781149.
   PubMed Web of Science ®Google Scholar
• Wu J, Nyborg WL. Ultrasound, cavitation bubbles and their interaction with cells. Adv Drug Deliv Rev. 2008;60(10):1103–16. doi:10.1016/j.addr.2008.03.009. PMID:18468716.
   PubMed Web of Science ®Google Scholar
• Wamel AV, Healey A, Sontum PC, Kvale S, Bush N, Bamber J, de Lange Davies C. Acoustic Cluster Therapy (ACT) – pre-clinical proof of principle for local drug delivery and enhanced uptake. J Control Release. 2016;224:158–64. doi:10.1016/j.jconrel.2016.01.023. PMID:26774223.
   PubMed Web of Science ®Google Scholar
• Tsutsui JM, Xie F, Porter RT. The use of microbubbles to target drug delivery. Cardiovasc Ultrasound. 2004;2:23. doi:10.1186/1476-7120-2-23. PMID:15546496.
   PubMedGoogle Scholar
• Pitt WG, Husseini GA, Staples BJ. Ultrasonic drug delivery–a general review. Expert Opin Drug Deliv. 2004;1(1):37–56. doi:10.1517/17425247.1.1.37. PMID:16296719.
   PubMedGoogle Scholar
• Sennoga CA, Kanbar E, Auboire L, Dujardin PA, Fouan D, Escoffre JM, Bouakaz A. Microbubble-mediated ultrasound drug-delivery and therapeutic monitoring. Expert Opin Drug Deliv. 2017;14(9):1031–43. doi:10.1080/17425247.2017.1266328. PMID:27892760.
   PubMed Web of Science ®Google Scholar
• Klibanov AL, Shevchenko TI, Raju BI, Seip R, Chin CT. Ultrasound-triggered release of materials entrapped in microbubble-liposome constructs: a tool for targeted drug delivery. J Control Release. 2010;148(1):13–7. doi:10.1016/j.jconrel.2010.07.115. PMID:20691227.
   PubMed Web of Science ®Google Scholar
• Huang FY, Mei WL, Li YN, Tan GH, Dai HF, Guo JL, Wang H, Huang YH, Zhao HG, Zhou SL, et al. The antitumour activities induced by pegylated liposomal cytochalasin D in murine models. Eur J Cancer. 2012;48(14):2260–69. doi:10.1016/j.ejca.2011.12.018. PMID:22257793.
   PubMed Web of Science ®Google Scholar
• Huang FY, Huang FR, Chen B, Liu Q, Wang H, Zhou SL, Zhao HG, Huang YH, Lin YY, Tan GH. Microencapsulation of tumor lysates and live cell engineering with MIP-3alpha as an effective vaccine. Biomaterials. 2015;53:554–65. doi:10.1016/j.biomaterials.2015.02.123. PMID:25890751.
   PubMed Web of Science ®Google Scholar
• Fushimi T, Kojima A, Moore MA, Crystal RG. Macrophage inflammatory protein 3alpha transgene attracts dendritic cells to established murine tumors and suppresses tumor growth. J Clin Invest. 2000;105(10):1383–93. doi:10.1172/JCI7548. PMID:10811846.
   PubMed Web of Science ®Google Scholar
• Racoosin EL, Swanson JA. Macrophage colony-stimulating factor (rM-CSF) stimulates pinocytosis in bone marrow-derived macrophages. J Exp Med 1989;170(5):1635–48. doi:10.1084/jem.170.5.1635. PMID:2681516.
   PubMed Web of Science ®Google Scholar
• Panaretakis T, Kepp O, Brockmeier U, Tesniere A, Bjorklund AC, Chapman DC, Durchschlag M, Joza N, Pierron G, van Endert P, et al. Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death. EMBO J. 2009;28(5):578–90. doi:10.1038/emboj.2009.1. PMID:19165151.
   PubMed Web of Science ®Google Scholar
• Kazama H, Ricci JE, Herndon JM, Hoppe G, Green DR, Ferguson TA. Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein. Immunity. 2008;29(1):21–32. doi:10.1016/j.immuni.2008.05.013. PMID:18631454.
   PubMed Web of Science ®Google Scholar
• Lindau D, Gielen P, Kroesen M, Wesseling P, Adema GJ. The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells. Immunology. 2013;138(2):105–15. doi:10.1111/imm.12036. PMID:23216602.
   PubMed Web of Science ®Google Scholar
• Yan WC, Chua QW, Ong XJ, Sharma VK, Tong YW, Wang CH. Fabrication of ultrasound-responsive microbubbles via coaxial electrohydrodynamic atomization for triggered release of tPA. J Colloid Interface Sci. 2017;501:282–93. doi:10.1016/j.jcis.2017.04.073. PMID:28460221.
   PubMed Web of Science ®Google Scholar
• Liao WH, Hsiao MY, Lo CW, Yang HS, Sun MK, Lin FH, Chang Y, Chen WS. Intracellular triggered release of DNA-quaternary ammonium polyplex by ultrasound. Ultrason Sonochem. 2017;36:70–77. doi:10.1016/j.ultsonch.2016.11.002. PMID:28069241.
   PubMed Web of Science ®Google Scholar
• Wang J, Li P, Tian R, Hu W, Zhang Y, Yuan P, Tang Y, Jia Y, Zhang L. A novel microbubble capable of ultrasound-triggered release of drug-loaded nanoparticles. J Biomed Nanotechnol. 2016;12(3):516–24. doi:10.1166/jbn.2016.2181. PMID:27280249.
   PubMed Web of Science ®Google Scholar
• Graham SM, Carlisle R, Choi JJ, Stevenson M, Shah AR, Myers RS, Fisher K, Peregrino MB, Seymour L, Coussios CC. Inertial cavitation to non-invasively trigger and monitor intratumoral release of drug from intravenously delivered liposomes. J Control Release. 2014;178:101–7. doi:10.1016/j.jconrel.2013.12.016. PMID:24368302.
   PubMed Web of Science ®Google Scholar
• Wang X, Guo S, Lu S, Zhou J, Li J, Xia S. Ultrasound-induced release of GDNF from lipid coated microbubbles injected into striatum reduces hypoxic-ischemic injury in neonatal rats. Brain Res Bull. 2012;88(5):495–500. doi:10.1016/j.brainresbull.2012.05.001. PMID:22579834.
   PubMed Web of Science ®Google Scholar
• Ye J, Ma C, Hsueh EC, Dou J, Mo W, Liu S, Han B, Huang Y, Zhang Y, Varvares MA, et al. TLR8 signaling enhances tumor immunity by preventing tumor-induced T-cell senescence. EMBO Mol Med. 2014;6(10):1294–311. doi:10.15252/emmm.201403918. PMID:25231413.
   PubMed Web of Science ®Google Scholar
• Croci DO, Zacarias Fluck MF, Rico MJ, Matar P, Rabinovich GA, Scharovsky OG. Dynamic cross-talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment. Cancer Immunol Immunother. 2007;56(11):1687–700. doi:10.1007/s00262-007-0343-y. PMID:17571260.
   PubMed Web of Science ®Google Scholar
• Whiteside TL. The tumor microenvironment and its role in promoting tumor growth. Oncogene. 2008;27(45):5904–12. doi:10.1038/onc.2008.271. PMID:18836471.
   PubMed Web of Science ®Google Scholar
• Uyttenhove C, Pilotte L, Theate I, Stroobant V, Colau D, Parmentier N, Boon T, Van den Eynde BJ. Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat Med. 2003;9(10):1269–74. doi:10.1038/nm934. PMID:14502282.
   PubMed Web of Science ®Google Scholar
• Dong H, Strome SE, Salomao DR, Tamura H, Hirano F, Flies DB, Roche PC, Lu J, Zhu G, Tamada K, et al. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med. 2002;8(8):793–800. doi:10.1038/nm730. PMID:12091876.
   PubMed Web of Science ®Google Scholar
• Peng G, Wang HY, Peng W, Kiniwa Y, Seo KH, Wang RF. Tumor-infiltrating gammadelta T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway. Immunity. 2007;27(2):334–48. doi:10.1016/j.immuni.2007.05.020. PMID:17656116.
   PubMed Web of Science ®Google Scholar
• Kiniwa Y, Miyahara Y, Wang HY, Peng W, Peng G, Wheeler TM, Thompson TC, Old LJ, Wang RF. CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer. Clin Cancer Res. 2007;13(23):6947–58. doi:10.1158/1078-0432.CCR-07-0842. PMID:18056169.
   PubMed Web of Science ®Google Scholar
• Roncarolo MG, Gregori S, Battaglia M, Bacchetta R, Fleischhauer K, Levings MK. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev. 2006;212:28–50. doi:10.1111/j.0105-2896.2006.00420.x. PMID:16903904.
   PubMed Web of Science ®Google Scholar
• Kusmartsev S, Gabrilovich DI. Role of immature myeloid cells in mechanisms of immune evasion in cancer. Cancer Immunol Immunother. 2006;55(3):237–45. doi:10.1007/s00262-005-0048-z. PMID:16047143.
   PubMed Web of Science ®Google Scholar
• Wei S, Kryczek I, Zou L, Daniel B, Cheng P, Mottram P, Curiel T, Lange A, Zou W. Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma. Cancer Res. 2005;65(12):5020–6. doi:10.1158/0008-5472.CAN-04-4043. PMID:15958543.
   PubMed Web of Science ®Google Scholar
• Cochran MC, Eisenbrey J, Ouma RO, Soulen M, Wheatley MA. Doxorubicin and paclitaxel loaded microbubbles for ultrasound triggered drug delivery. Int J Pharm. 2011;414(1–2):161–70. doi:10.1016/j.ijpharm.2011.05.030. PMID:21609756.
   PubMed Web of Science ®Google Scholar
• Rapoport N, Nam KH, Gupta R, Gao Z, Mohan P, Payne A, Todd N, Liu X, Kim T, Shea J, et al. Ultrasound-mediated tumor imaging and nanotherapy using drug loaded, block copolymer stabilized perfluorocarbon nanoemulsions. J Control Release. 2011;153(1):4–15. doi:10.1016/j.jconrel.2011.01.022. PMID:21277919.
   PubMed Web of Science ®Google Scholar
• Gewirtz DA. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem Pharmacol. 1999;57(7):727–41. doi:10.1016/S0006-2952(98)00307-4. PMID:10075079.
   PubMed Web of Science ®Google Scholar
• Germann UA. P-glycoprotein–a mediator of multidrug resistance in tumour cells. Eur J Cancer. 1996;32A(6):927–44. doi:10.1016/0959-8049(96)00057-3.
   PubMed Web of Science ®Google Scholar
• Banerjee R, Tyagi P, Li S, Huang L. Anisamide-targeted stealth liposomes: a potent carrier for targeting doxorubicin to human prostate cancer cells. Int J Cancer. 2004;112(4):693–700. doi:10.1002/ijc.20452. PMID:15382053.
   PubMed Web of Science ®Google Scholar